Bowil Biotechsp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-11-16
Share capital
2 400 000,00 PLN
Registered address
Skandynawska 7, 84-120 Władysławowo, Poland

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 1.98mMedianUSD 244.19kAverageUSD 73.97m
Net profit
This companyUSD 428.18kMedianUSD 8.66kAverageUSD 3.21m
Operating costs
This companyUSD 1.45mMedianUSD 263.70kAverageUSD 67.37m
Assets
This companyUSD 3.65mMedianUSD 231.06kAverageUSD 47.07m

Bank accounts

Was a VAT taxpayer from 2007-09-27 to 2026-01-14. Removed from VAT register

Reason for removal: Art. 96 ust. 6-8

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

13 public aid cases recorded, with a total value of $350,238.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$3,964
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,961
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,936

European Funds

ProjectEU co-financing
Wzrost konkurencyjności i zwiększenie oddziaływania firmy Bowil Biotech poprzez wejście na nowe, międzynarodowe rynki zbytu dzięki realizacji inwestycji związanej z uruchomieniem produkcji nowego biomateriału do wytwarzania implantów, będącego wynikiem własnych prac badawczo-rozwojowych
$247.7K

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Norbert Wilandt — President of the Management Board & Management Board Member

Manner of representation

To make declarations of will and sign on behalf of the company, each member of the management board is authorized to act independently, regardless of the function held.

Ownership

OwnerShare valueStake
$648,298.22100%

Beneficial owners

Person
Artur Maksymilian Wilandt (42)
Konrad Waldemar Wilandt (41)
Norbert Wilandt (39)

Competitors

Name
Biovicosp. z o.o.
Fabryka Aparatury Elektromedycznej Famed ŁódźS.A.
Bifarmsp. z o.o.
Esvicosp. z o.o.
Metzer Medizin- Und Industrietechniksp. z o.o.
Profildentsp. z o.o.
Jacek Bartosiksp. k.
Optyk Plussp. z o.o.
Implaisp. z o.o.
Pressdots Technologysp. z o.o.

Change history

DateEvent
2016-04-07PKD change
2011-10-20PKD change
2010-09-29PKD change
2008-08-14Share capital change
2008-08-14PKD change

FAQ

Last updated: 2026-02-17